CA - Knight Therapeutics GAAP EPS of C$0.02 revenue of C$89.9M August, 10 2023 09:18 AM CA Inc. 2023-08-10 09:18:15 ET Knight Therapeutics press release ( OTCPK:KHTRF ): Q2 GAAP EPS of C$0.02. Revenue of C$89.9M (+18.6% Y/Y). For further details see: Knight Therapeutics GAAP EPS of C$0.02, revenue of C$89.9M